We are live on ! Find out more
BSX icon

Boston Scientific

1,643 hedge funds and large institutions have $135B invested in Boston Scientific in 2025 Q1 according to their latest regulatory filings, with 230 funds opening new positions, 667 increasing their positions, 553 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more first-time investments, than exits

New positions opened: 230 | Existing positions closed: 73

31% more call options, than puts

Call options by funds: $1.07B | Put options by funds: $819M

31% more funds holding in top 10

Funds holding in top 10: 3951 (+12)

21% more repeat investments, than reductions

Existing positions increased: 667 | Existing positions reduced: 553

12% more capital invested

Capital invested by funds: $120B → $135B (+$14.8B)

9% more funds holding

Funds holding: 1,5131,643 (+130)

0.19% less ownership

Funds ownership: 90.98%90.79% (-0.19%)

Holders
1,643
Holders Change
+130
Holders Change %
+8.59%
% of All Funds
22.03%
Holding in Top 10
51
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+30.77%
% of All Funds
0.68%
New
230
Increased
667
Reduced
553
Closed
73
Calls
$1.07B
Puts
$819M
Net Calls
+$256M
Net Calls Change
+$371M
Name Holding Trade Value Shares
Change
Change in
Stake
PF
401
Phoenix Financial
Israel
$10.7M -$2.83M -28,112 -21%
Wealth Enhancement Advisory Services
402
Wealth Enhancement Advisory Services
Minnesota
$10.6M +$2.5M +24,856 +31%
TI
403
Tidal Investments
Wisconsin
$10.5M -$1.56M -15,444 -13%
CI
404
Cavalier Investments
Georgia
$10.5M -$7.51M -74,593 -42%
CCM
405
Cinctive Capital Management
New York
$10.4M +$10.4M +103,559 New
RS
406
Robeco Schweiz
Switzerland
$10.4M -$1.14M -11,303 -10%
BPWM
407
Badgley Phelps Wealth Managers
Washington
$10.3M +$510K +5,068 +5%
M&T Bank
408
M&T Bank
New York
$10.3M -$1.04M -10,320 -9%
KRS
409
Kentucky Retirement Systems
Kentucky
$10.1M -$88.6K -880 -0.9%
SGH
410
Sivik Global Healthcare
Connecticut
$10.1M -$1.01M -10,000 -9%
SFM
411
Soros Fund Management
New York
$10.1M
CWM
412
Calamos Wealth Management
Illinois
$9.98M -$5.69M -56,510 -36%
VC
413
Vestor Capital
Illinois
$9.93M +$9.92M +98,478 New
RBA
414
Richard Bernstein Advisors
New York
$9.89M -$469K -4,653 -5%
NA
415
NewEdge Advisors
Louisiana
$9.66M +$694K +6,891 +8%
AAIS
416
ABN AMRO Investment Solutions
$9.6M +$804K +7,981 +9%
GAM
417
Generali Asset Management
Italy
$9.54M -$2.59M -25,766 -21%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
418
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$9.5M -$37M -367,579 -80%
BPCE
419
Bank Pictet & Cie (Europe)
Germany
$9.47M +$2.09M +20,805 +28%
MYAM
420
Meiji Yasuda Asset Management
Japan
$9.35M -$393K -3,905 -4%
CGH
421
Crossmark Global Holdings
Texas
$9.34M -$104K -1,028 -1%
KCM
422
Kennedy Capital Management
Missouri
$9.3M -$742K -7,367 -7%
Dodge & Cox
423
Dodge & Cox
California
$9.25M -$312K -3,100 -3%
LP
424
LMR Partners
United Kingdom
$9.22M -$952K -9,457 -9%
RBI
425
Raiffeisen Bank International
Austria
$9.2M +$410K +4,068 +5%

BSX Hedge Fund Activity: Q1 2025 in Review

1,643 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2025, worth a combined $135B — up 12% from $120B a quarter earlier.

Buyers outnumbered sellers: 230 funds opened new BSX positions and 73 closed out — a net gain of 157 holders — while 667 added to existing stakes and 553 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $532M. The largest seller was Franklin Resources, cutting an estimated $915M.

  • 1,643 institutional investors held Boston Scientific (BSX) as of Q1 2025, up from 1,513 in Q4 2024.
  • Funds reported $135B of Boston Scientific stock for Q1 2025, up 12% quarter-over-quarter.
  • 230 funds opened new Boston Scientific positions in Q1 2025 and 73 closed out, a net change of +157 holders.
  • The largest Boston Scientific buyer in Q1 2025 was JP Morgan Chase, an estimated $532M added.
  • The largest Boston Scientific seller in Q1 2025 was Franklin Resources, an estimated $915M sold.

Based on aggregated 13F filings for Q1 2025.